Daniel Polsky, Ph.D., Executive Director of the Leonard Davis Institute of Health Economics, is a professor of Medicine in the Perelman School of Medicine and the Robert D. Eilers Professor of Health Care Management in the Wharton School. He currently serves on the Congressional Budget Office's Panel of Health Advisers and The Institute of Medicine Board on Population Health and Public Health Practice. He was the Senior Economist on health issues at the President's Council of Economic Advisers in 2007-08. His research was awarded Academy Health's Article of the Year in 2014. He received a Ph.D. in Economics from the University of Pennsylvania in May 1996 and a Master of Public Policy from the University of Michigan in 1989. His areas of interest include health care access, workforce, and economic evaluation of medical and behavioral health interventions. He is a coauthor of the book "Economic Evaluation in Clinical Trials" published by Oxford University Press.
In addition to his publications in the Journal of Health Economics, Health Economics, Health Services Research, and Medical Care, he is a coauthor of the book “Economic Evaluation in Clinical Trials” recently published by Oxford University Press.
Polsky D. Doshi JA, Escarce J, Manning W, Paddock SM, Cen L, Rogowski J: The health effects of medicare for the near-elderly uninsured. Health Services Research. 2009; 44(3):926-945.
Decker SL, Doshi JA, Knaup AE, Polsky D: Health service use among the previously uninsured: Is subsidized health insurance enough? Health Economics. In press.
Polsky D, Glick HA, Yang J, Subramaniam GA, Poole SA, Woody GE: Cost-effectiveness of extended Buprenorphine-Naloxone treatment for opioid-addicted youth: Data from a randomized trial. Addiction. 2010; 105:1616-1624.
Polsky D, Glick HA, Willke R, Schulman K: Confidence intervals for cost effectiveness ratios: A comparison of four methods. Health Economics. 1997; 6:243-252.